510(k) Report

510(k) · Cleared

Cleared

PanopticAI Vital Signs

K240890510(k) TraditionalCleared Dec 23, 2024266-day reviewClass II21 CFR 870.2785

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

PanopticAI technologies Limited · QME Software For Optical Camera-Based Measurement Of Pulse Rate, Heart Rate, Breathing Rate, And/Or Respiratory Rate

Cleared on Dec 23, 2024 as substantially equivalent to K211906 (Oxehealth Limited, 2021) after a 266-day review. Its family tree reaches back 2 generations to 2021. 1 later device descends from it.

Decided
Dec 23, 2024
Review
266 days
Class
Class II
Product code
QME
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN200019 (2021). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2026: 1 descendant clearedDEN200019 · Oxehealth Vital Signs · Oxehealth Limited · 2021K211906 · Vital Signs · Oxehealth Limited · 20212020202220242026
Descendants, by generation 1 generation forward: 1 descendant K211906 · Vital Signs · Oxehealth Limited · 2021DEN200019 · Oxehealth Vital Signs · Oxehealth Limited · 20210
  1. Root · 2 generations backDEN200019 Oxehealth Vital SignsOxehealth Limited · 2021
  2. 1 generation backK211906 Vital SignsOxehealth Limited · 2021
  3. This deviceK240890 PanopticAI Vital SignsPanopticAI technologies Limited · 2024
  4. Descendant · cites it directly · 0 of its ownK260066 PanopticAI Vital Signs (1.6.1-22)PanopticAI Technologies Limited · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K260066PanopticAI Vital Signs (1.6.1-22)PanopticAI Technologies Limited · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN200019Oxehealth Vital SignsOxehealth Limited2021—
−1K211906Vital SignsOxehealth Limited2021—
0 (this device)K240890PanopticAI Vital SignsPanopticAI technologies Limited2024—
+1K260066PanopticAI Vital Signs (1.6.1-22)PanopticAI Technologies Limited2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K240890, 2021–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QME? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QME device

  1. #1 K211906 Vital Signsscore 28.7 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K211906Vital Signs
Summary page 6
…respiratory rate 3.4. Regulation Number: 21 CFR 870.2785 3.5. Device Class: Class II 3.6. Product Code: QME 4. Identification of Predicate Device K211906 Oxehealth Vital Signs Page 2 of 9…
Oxehealth Limited2021—

Also cleared against K211906: 8 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260066PanopticAI Vital Signs (1.6.1-22)PanopticAI Technologies Limited20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 2 companies; a new generation was cleared every 3.4 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K260066 (PanopticAI Technologies Limited, 2026) has gone furthest, with 0 descendants of its own.
  • 8 other devices also cite its predicate K211906.

How does its category compare?

All QME devices

QME Software For Optical Camera-Based Measurement Of Pulse Rate, Heart Rate, Breathing Rate, And/Or Respiratory Rate: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · QME

4so far in 2026, the most since 2007

2021: 22022: 12023: 12024: 32025: 22026 (partial year): 4
2007high 4 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QME

266in 2024

2024: 266 days median2026 (partial year): 190 days median
2007high 266 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QME

No recall names QME since 2007.

Adverse event reports per year · QME

No MAUDE report names QME since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20212—00
20221—00
20231—00
2024326600
20252—00
202641900—

What is it indicated for?

The PanopticAl Vital Signs device is intended for noninvasive spot measurement of pulse rate when the subject is still. It is software for assessing facial video stream captured from a specified smartphone or tablet camera. The PanopticAl Vital Signs device is intended for use by healthcare professionals. The device is only intended to be used in healthy subjects. The PanopticAl Vital Signs device is indicated for use on humans 18 to 60 years of age who…

Read the full statement (119 words)

The PanopticAl Vital Signs device is intended for noninvasive spot measurement of pulse rate when

the subject is still. It is software for assessing facial video stream captured from a specified

smartphone or tablet camera.

The PanopticAl Vital Signs device is intended for use by healthcare professionals. The device is only

intended to be used in healthy subjects.

The PanopticAl Vital Signs device is indicated for use on humans 18 to 60 years of age who do not

require critical care or continuous monitoring.

The PanopticAl Vital Signs device is not intended to be the sole method to assess a subject's

physical health condition. The pulse rate measurements it provides should complement, not replace,

professional medical care and/or medication.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K240890: PanopticAI Vital Signs.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K240890

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026